An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

[1]  T. Lawrie,et al.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia. , 2016, The Cochrane database of systematic reviews.

[2]  H. Ngan,et al.  Current management of gestational trophoblastic disease , 2015 .

[3]  F. Sweep,et al.  Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. , 2012, Gynecologic oncology.

[4]  D. Provencher,et al.  Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Lurain.  Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. , 2011, American journal of obstetrics and gynecology.

[6]  Neil J Sebire,et al.  Gestational trophoblastic disease , 2010, The Lancet.

[7]  R. Berkowitz,et al.  Current management of gestational trophoblastic diseases. , 2009, Gynecologic oncology.

[8]  D. Eton,et al.  Combining Distribution- and Anchor-Based Approaches to Determine Minimally Important Differences , 2005, Evaluation & the health professions.

[9]  D. Cella,et al.  Integrating health-related quality of life into cross-national clinical trials , 1993, Quality of Life Research.

[10]  J. Lurain.  Pharmacotherapy of gestational trophoblastic disease , 2003, Expert opinion on pharmacotherapy.

[11]  J. Lurain,et al.  Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. , 1995, American journal of obstetrics and gynecology.

[12]  R. Berkowitz,et al.  Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease , 1986 .

[13]  R. Berkowitz,et al.  Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. , 1986, Gynecologic oncology.